HIGHLIGHTS
- who: Tanvi Mehta from the (UNIVERSITY) have published the paper: Using group testing in a two-phase epidemiologic design to identify the effects of a large number of antibody reactions on disease risk, in the Journal: (JOURNAL)
- what: The authors propose a two-phase group testing design to more efficiently screen numerous antibody effects in a case-control setting. The authors evaluate the two-phase group testing design through simulations and example data and find that it substantially reduces the number of assays required relative to standard case-control and group testing designs while maintaining . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.